Introducing national guidelines on perioperative chemotherapy for gastric cancer in Norway: A retrospective audit

European Journal of Surgical Oncology

Volumn 36, Issue 7, 2010, Pages 610-616

  Holmebakk T ^a   Frykholm, G ^b,c   Viste, A ^d,e  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF BERGEN   (Norway)

Author keywords

Gastric cancer; Guidelines; Perioperative chemotherapy; Surgery; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MORBIDITY; MORTALITY; NORWAY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH CANCER; TOXICITY;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; NEOADJUVANT THERAPY; NORWAY; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 77953915324     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.05.006     Document Type: Article

References (25)

1. Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355 (2006) 11-20
2. Helsedirektoratet. Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av pasienter med magekreft. www.helsedirektoratet.no/publikasjoner/nasjonale_faglige_retningslinjer
3. The Norwegian Cancer Registry. Cancer in Norway (2008). www.kreftregisteret.no/no/Generelt/Publikasjoner/Cancer-in-Norway/Cancer-in-Norway-2008/
4. Birkmeyer J.D., Sun Y., Wong S.L., et al. Hospital volume and late survival after cancer surgery. Ann Surg 245 (2007) 777-783
5. Preacher K.J. Calculation for the chi-square test: an interactive calculation tool for chi-square tests of goodness of fit and independence [Computer software] (2001, April). www.quantpsy.org
6. Boige V., Pignon J., Saint-Aubert B., et al. Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial. J Clin Oncol 25 18S (2007) 4510 Abstract
7. Findlay M., Cunningham D., Norman A., et al. A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with infusion 5-fluorouracil (ECF). Ann Oncol 5 7 (1994) 609-616
8. Smith I.E., Walsh G., Jones A., et al. High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer. J Clin Oncol 13 2 (1995) 424-429
9. Webb A., Cunningham D., Scarffe J.H., et al. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advance esophagogastric cancer. J Clin Oncol 15 1 (1997) 261-267
10. Cunningham D., Starling N., Rao S., et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 358 (2008) 36-46
11. In: Sobin L.H., and Wittekind C.H. (Eds). International Union Against Cancer (UICC): TNM classification of malignant tumours. 6th ed. (2002), John Wiley, New York
12. Kwee R.M., and Kwee T.C. Imaging in local staging of gastric cancer: a systematic review. J Clin Oncol 25 15 (2007) 2107-2116
13. Yan C., Zhu Z.G., Yan M., et al. Value of multidetector-row computed tomography in preoperative T and N staging of gastric carcinoma: a large-scale Chinese study. J Surg Oncol 100 3 (2009) 205-214
14. Kwee R.M., and Kwee T.C. Imaging in assessing lymph node status in gastric cancer. Gastric Cancer 12 1 (2009) 6-22
15. Stockeld D., Tennvall J., Wagenius G., et al. A Swedish study of chemoradiation in squamous cell carcinoma of the esophagus. Acta Oncol 40 5 (2001) 566-573
16. Wiig J.N., Larsen S.G., Dueland S., et al. Clinical outcome in patients with complete pathologic response (pT0) to preoperative irradiation/chemo-irradiation operated for locally advanced or locally recurrent rectal cancer. J Surg Oncol 92 1 (2005) 70-75
17. Sun P., Xiang J.B., and Chen Z.Y. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg 96 (2009) 26-33
18. Thompson A.M., Rapson T., Gilbert F.J., et al. for the Scottish audit of gastric and oesophageal cancer, Hospital volume does not influence long-term survival of patients undergoing surgery for oesophageal or gastric cancer. Br J Surg 94 (2007) 578-584
19. McCulloch P., Ward J., Tekkis P.P., ASCOT Group of Surgeons, and British Oesophago-Gastric Cancer Group. Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ 327 (2003) 1192-1197
20. Lepage C., Sant M., Verdecchia A., et al. for the EUROCARE Working Group. Operative mortality after gastric cancer resection and long-term survival differences across Europe. Brit J Surg 97 (2010) 235-239
21. Birkmeyer J.D., Stukel T.A., Siewers A.E., et al. Surgeon volume and operative mortality in the United States. N Engl J Med 349 (2003) 2117-2127
22. Damhuis R.A., Meurs C.J., Dijkhuis C.M., et al. Hospital volume and post-operative mortality after resection for gastric cancer. Eur J Surg Oncol 28 (2002) 401-405
23. Skipworth R.J.E., Parks R.W., Stephens N.A., et al. The relationship between hospital volume and post-operative mortality rates for upper gastrointestinal cancer resections: Scotland 1982-2003. Eur J Surg Oncol 36 (2010) 141-147
24. Wibe A., Møller B., Norstein J., et al. A national strategic change in treatment policy for rectal cancer-implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 45 7 (2002) 857-866
25. Martling A., Holm T., Rutqvist H., et al. Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg 92 (2005) 225-229